iApotek Int AB (publ) (XSAT:IAPO) entered into a letter of intent to acquire Eprix AB on May 17, 2018. iApotek Int AB (publ) (XSAT:IAPO) agreed to acquire Eprix AB for SEK 13 million on August 16, 2018. As part of the consideration, iApotek Int AB will pay SEK 3 million in cash and SEK 8 million in iApotek shares. Based on the sales and EBITDA earnings twelve months ahead from the date of admission, additional purchase price, consisting of shares in iApotek, may be paid to the seller up to SEK 2 million. Eprix had SEK 18 million in revenue in 2017. Eprix previous owner will continue with an active role in Eprix AB. The deal is expected to close in mid September 2018.